Metrics president and founder, Phil Hodges, will retire after 19 years with the company. The company opened in 1994 as a small contract analytical lab with four employees and has since grown to more than 300. The company now offers first-time-in-man development, Phase I, II and III clinical trial materials, as well as full analytical methods development and validation from its custom-built 100,000 sq.-ft. facility in Greenville, NC, which includes a highly potent products containment suite. Last year, Metrics was acquired by Mayne Pharma, a pharmaceutical company based in Melbourne, Australia.
“I built this business and I am proud of it,” said Mr. Hodges, “And that’s what I loved about the Mayne deal, they really got it, they understood what we are doing here. But I’ll be honest, after 19 years, I’m ready to get out of day-today operations and go do something different.” Mr. Hodges will continue to serve on the board of directors at Mayne Pharma.